Data / Research funding / Transplantation
Transplantation: 2,381 NIH awards ($2.9B) to 411 organizations
2,381 NIH awards ($2.9B) in the NIH spending category Transplantation, to 411 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 2,381 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | NIH | National Cancer Institute | 2021 to 2025 | $30,268,190 | March 1, 1998 | February 29, 2028 | SHAW, BRONWEN | reporter.nih.gov |
| PPDs Application for the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $26,732,375 | June 12, 2023 | April 30, 2028 | SEVER, MICHELLE LYNN | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $16,391,930 | July 1, 2025 | June 30, 2029 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,471,597 | September 14, 2021 | June 30, 2028 | MADSEN, JOREN C | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| Lung Transplant Clinical Trial Network (LT-CTN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,392,000 | June 1, 2025 | May 31, 2028 | PALMER, SCOTT M | reporter.nih.gov |
| Extracellular Vesicles for Gaining Insights into Tissue Senescent Signatures: A SenNET Pilot and Exploratory Project | NIH | National Institute on Aging | 2021 to 2025 | $13,842,784 | September 30, 2021 | August 31, 2027 | KUCHEL, GEORGE A | reporter.nih.gov |
| A Tolerance Approach to Xenotransplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $13,161,555 | September 15, 2000 | December 31, 2026 | SYKES, MEGAN | reporter.nih.gov |
| The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center | NIH | National Institute on Aging | 2021 to 2025 | $12,705,171 | September 30, 2021 | August 31, 2026 | NIXON, ANDREW B. | reporter.nih.gov |
| Tissue and organ specific human B cell immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $12,146,380 | April 1, 2019 | March 31, 2025 | LUND, FRANCES E. | reporter.nih.gov |
| Advancing brain health research through male germline editing in marmosets | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,061,296 | August 1, 2021 | May 31, 2027 | HERMANN, BRIAN PETER | reporter.nih.gov |
| Human anti-viral immune responses in tissues and circulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,930,741 | January 1, 2017 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Liver Cirrhosis Network: Scientific and Data Coordination Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,655,826 | August 28, 2021 | July 31, 2027 | SMITH, ABIGAIL | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,640,870 | August 26, 2021 | September 30, 2024 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Lung Transplant Consortium - Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,634,917 | August 5, 2022 | July 31, 2027 | PALMER, SCOTT M | reporter.nih.gov |
| Human Nociceptor and Spinal Cord Molecular Signature Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $9,264,871 | September 19, 2022 | August 31, 2027 | PRICE, THEODORE J. | reporter.nih.gov |
| NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $7,818,967 | September 15, 2021 | September 14, 2022 | MOLINA, DANIEL | reporter.nih.gov |
| Stanford Tissue Mapping Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,785,758 | September 23, 2022 | June 30, 2026 | SNYDER, MICHAEL P. | reporter.nih.gov |
| A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,767,541 | April 15, 2021 | March 31, 2027 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| Application of Progenitor Niche Signals to Ex Vivo Nephrogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,389,413 | September 15, 2021 | June 30, 2027 | OXBURGH, LEIF | reporter.nih.gov |
| Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,360,026 | July 1, 2016 | June 30, 2030 | ADAMS, ANDREW B | reporter.nih.gov |
| TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,251,380 | September 1, 2021 | May 31, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,099,019 | August 1, 2022 | May 31, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| Long Term Follow up of the Lung Transplant Outcomes Group Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,078,569 | June 15, 2019 | May 31, 2027 | CHRISTIE, JASON D | reporter.nih.gov |
| Overcoming Barriers to retinal ganglion cell replacement in experimental glaucoma | NIH | National Eye Institute | 2021 to 2025 | $7,031,142 | September 30, 2021 | July 31, 2027 | MEYER, JASON STEPHEN | reporter.nih.gov |
| Exosomes as mediators of cardiac injury and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,022,243 | September 1, 2017 | June 30, 2029 | KISHORE, RAJ | reporter.nih.gov |
| Personalized prime editing as a platform for hepatic inborn errors of metabolism | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $6,886,793 | September 20, 2024 | August 31, 2028 | AHRENS-NICKLAS, REBECCA CLARE | reporter.nih.gov |
| Subcutaneous Drug Development for Portal Hypertension Ascites | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,758,500 | September 22, 2014 | July 31, 2027 | CASTILLO, GERARDO M. | reporter.nih.gov |
| The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantation | NIH | National Institute on Aging | 2021 to 2025 | $6,330,805 | June 15, 2018 | May 31, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,882,740 | August 26, 2021 | May 31, 2028 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Novel Biologic Therapies for GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,851,412 | February 1, 2010 | June 30, 2026 | KEAN, LESLIE S | reporter.nih.gov |
| Descemet Endothelial Thickness Comparison Trial (DETECT) | NIH | National Eye Institute | 2021 to 2025 | $5,663,165 | April 1, 2021 | March 31, 2027 | ROSE-NUSSBAUMER, JENNIFER | reporter.nih.gov |
| A Randomized Trial of Fistula vs. Graft Arteriovenous Vascular Access in Older Adults with End-Stage Kidney Disease on Hemodialysis: The AV ACCESS Trial | NIH | National Institute on Aging | 2021 to 2025 | $5,580,574 | September 1, 2021 | August 31, 2027 | MUREA, MARIANA | reporter.nih.gov |
| THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE | NIH | National Institute of Mental Health | 2023 to 2025 | $5,429,596 | August 23, 2025 | August 22, 2026 | MOORE, DAVID J | reporter.nih.gov |
| Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,224,210 | May 25, 2023 | April 30, 2028 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,162,956 | March 25, 2022 | February 28, 2027 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Safety and efficacy of Belatacept in heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,158,955 | June 6, 2023 | March 31, 2028 | HABAL, MARLENA | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Novel Strategies to Improve Blood Transfusion Practice | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,119,758 | August 15, 2022 | July 31, 2027 | LUO, HONGBO R | reporter.nih.gov |
| Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,116,475 | June 9, 2023 | March 31, 2028 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,061,587 | May 10, 2021 | April 30, 2027 | TRAPNELL, BRUCE C | reporter.nih.gov |
| Composite porcine islet-kidney xenotransplants to cure diabetes and renal failure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,035,116 | May 21, 2020 | April 30, 2026 | SACHS, DAVID H | reporter.nih.gov |
| Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,032,505 | September 21, 2024 | July 31, 2029 | JENQ, ROBERT | reporter.nih.gov |
| 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,023,972 | April 1, 2022 | March 31, 2029 | SHAW, BRONWEN | reporter.nih.gov |
| 14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,865,046 | September 25, 2017 | May 31, 2028 | FREEDMAN, BARRY IRA | reporter.nih.gov |
| Investigating the heterogeneity and coordination of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,840,269 | August 1, 2020 | July 31, 2027 | LU, RONG | reporter.nih.gov |
| Program to promote lung regeneration and block fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,819,926 | February 15, 2020 | February 14, 2026 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,782,581 | August 31, 2021 | July 31, 2023 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,780,411 | April 5, 2019 | March 31, 2026 | WILCOX, DAVID ALLEN | reporter.nih.gov |
| Transplanting Lungs from Uncontrolled Donation after Circulatory Death | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $4,714,267 | July 8, 2022 | June 30, 2027 | WALL, STEPHEN P | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| Diabetes Endothelial Keratoplasty Study: Impact of Diabetes on Corneal Transplant Success and Cell Loss | NIH | National Eye Institute | 2021 to 2025 | $4,496,381 | May 1, 2021 | April 30, 2026 | GAL, ROBIN L | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,466,979 | May 1, 2018 | April 30, 2025 | MADSEN, JOREN C | reporter.nih.gov |
| A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,411,202 | December 21, 2016 | June 30, 2026 | SACHA, JONAH B. | reporter.nih.gov |
| Cell-cell interactions governing lung epithelial progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,407,300 | March 15, 2020 | January 31, 2027 | KIM, CARLA F. | reporter.nih.gov |
| Neonatal porcine islet xenografts for the treatment of type 1 diabetes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,363,576 | September 1, 2010 | June 30, 2025 | KIRK, ALLAN D. | reporter.nih.gov |
| Charting human islet maturation via combined soft nanoelectronics and single-cell spatial transcriptomics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,276,659 | September 17, 2021 | May 31, 2027 | LIU, JIA | reporter.nih.gov |
| CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,188,152 | March 17, 2020 | June 30, 2029 | FORD, MANDY L | reporter.nih.gov |
| Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,065,243 | March 15, 2021 | February 28, 2027 | DEBAUN, MICHAEL R. | reporter.nih.gov |
| Diabetes Endothelial Keratoplasty Study(DEKS): Impact of Diabetes on Corneal Transplant Success and Cell Loss | NIH | National Eye Institute | 2021 to 2025 | $4,021,141 | May 1, 2021 | April 30, 2027 | LASS, JONATHAN H | reporter.nih.gov |
| Base editing and prime editing for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,000,055 | January 1, 2021 | June 30, 2030 | WEISS, MITCHELL J | reporter.nih.gov |
| Combining Targeted RIT and Synergistic Novel Agent-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,984,924 | June 1, 2020 | May 31, 2027 | OROZCO, JOHNNIE JOSE | reporter.nih.gov |
| Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing | NIH | National Cancer Institute | 2021 to 2025 | $3,984,664 | July 16, 2018 | January 31, 2027 | BICKEL, KELLIE | reporter.nih.gov |
| Engineered Stem Cells for Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,984,462 | February 1, 2018 | March 31, 2027 | REGNIER, MICHAEL | reporter.nih.gov |
| A single antiviral to treat multiple opportunistic infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,962,651 | June 15, 2014 | March 31, 2026 | REMISZEWSKI, STACY | reporter.nih.gov |
| Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,911,609 | August 1, 2015 | July 31, 2028 | KAPUR, REUBEN | reporter.nih.gov |
| Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,866,357 | September 17, 2021 | August 31, 2027 | STEINBACH, WILLIAM J | reporter.nih.gov |
| Gaining insight into psychiatric disease by engineering piece by piece the human brain in vitro | NIH | National Institute of Mental Health | 2025 | $3,812,108 | August 1, 2015 | August 19, 2029 | PASCA, SERGIU | reporter.nih.gov |
| BMT Survivor Study-2 (BMTSS-2) | NIH | National Cancer Institute | 2021 to 2023 | $3,811,745 | April 1, 2019 | March 31, 2025 | BHATIA, SMITA | reporter.nih.gov |
| Contact Pathway Inhibitor to Prevent Vascular Access Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,810,461 | June 1, 2023 | March 31, 2027 | LORENTZ, CHRISTINA U | reporter.nih.gov |
| Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,710,340 | September 1, 2023 | August 31, 2028 | WEISS, MITCHELL J | reporter.nih.gov |
| Harnessing the therapeutic potential of neural crest cells by manipulating the primary cilium | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $3,694,614 | September 14, 2017 | June 30, 2025 | BRUGMANN, SAMANTHA A | reporter.nih.gov |
| Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $3,687,540 | September 7, 2017 | June 30, 2032 | DIPERSIO, JOHN F. | reporter.nih.gov |
| Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,648,726 | August 15, 2015 | May 31, 2026 | SARANTOPOULOS, STEFANIE | reporter.nih.gov |
| Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,632,845 | September 20, 2024 | June 30, 2026 | ELGEBALY, SALWA A | reporter.nih.gov |
| HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,601,018 | April 9, 2021 | March 31, 2027 | HSU, KATHARINE C | reporter.nih.gov |
| PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,559,912 | March 6, 2019 | February 28, 2029 | WEINBERG, ADRIANA | reporter.nih.gov |
| Preventing GVHD by inhibition of alloantigen presentation in the gut | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,543,040 | July 1, 2019 | June 30, 2027 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Ocular Immune Regulation by Mesenchymal Stem Cells | NIH | National Eye Institute | 2021 to 2025 | $3,542,949 | April 1, 2015 | September 14, 2028 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Platform for Extended Kidney Preservation Via Subnormothermic Perfusion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,527,840 | September 20, 2024 | December 31, 2026 | KOPPARTHY, VARUN LINGAIAH | reporter.nih.gov |
| Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,525,766 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,521,212 | September 15, 2020 | August 31, 2025 | BERGER, STUART | reporter.nih.gov |
| Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,469,202 | September 1, 2021 | August 31, 2027 | MOSTOUFI-MOAB, SOGOL | reporter.nih.gov |
| Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,457,708 | July 1, 2021 | April 30, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Immunobiology of Lung Injury and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,455,443 | January 21, 2019 | December 31, 2024 | MOORE, BETHANY B. | reporter.nih.gov |
| Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,417,341 | January 15, 2022 | December 31, 2028 | LAVINE, KORY J. | reporter.nih.gov |
| BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $3,403,884 | August 1, 2018 | July 31, 2025 | SPINDLER, KURT PAUL | reporter.nih.gov |
| Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,375,497 | February 18, 2022 | January 31, 2027 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,369,470 | July 7, 2016 | December 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Mechanisms of Sensitization in High Risk Corneal Grafts | NIH | National Eye Institute | 2021 to 2025 | $3,336,083 | August 1, 2000 | July 31, 2027 | DANA, REZA | reporter.nih.gov |
| Hydrogels for human beta cell survival, function and evasion of immune rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,331,035 | September 15, 2022 | May 31, 2027 | GARCIA, ANDRES J | reporter.nih.gov |
| Enhancing Treg Therapeutic Efficacy in GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,322,892 | April 15, 2014 | March 31, 2027 | BLAZAR, BRUCE R | reporter.nih.gov |
| Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,318,431 | September 19, 2022 | July 31, 2027 | MORELLI, ADRIAN E. | reporter.nih.gov |
| Career Development in Pediatric and Medical Oncology | NIH | National Cancer Institute | 2021 to 2025 | $3,314,336 | September 30, 1997 | August 31, 2026 | MESHINCHI, SOHEIL | reporter.nih.gov |
| Integrating a culturally competent APOL1 genetic testing program into living donor evaluation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,312,983 | April 1, 2021 | March 31, 2027 | AGRAWAL, AKANSHA | reporter.nih.gov |
| Immunobiology of the normal and injured lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,312,758 | January 1, 2022 | December 31, 2028 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Comprehensive Cardiac Structure-Function Analysis in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,301,355 | February 4, 2014 | April 30, 2027 | MARKL, MICHAEL | reporter.nih.gov |
| Pathogenesis of lung injury mediated by lung-restricted antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,293,690 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,293,620 | September 1, 2020 | June 30, 2025 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Evolution of T cell immunity in blood and tissues over childhood | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,243,813 | March 16, 2022 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| Mechanisms of specification, quiescence, and regeneration of primordial germ cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,240,052 | June 1, 2021 | September 30, 2026 | WESSEL, GARY M | reporter.nih.gov |
| Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,231,750 | August 15, 2016 | February 28, 2029 | HARRINGTON, DANIEL A | reporter.nih.gov |
| Targeting innate immunity for induction of robust renal allograft tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,224,166 | July 25, 2023 | April 30, 2028 | KAWAI, TATSUO | reporter.nih.gov |
| Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,218,917 | August 15, 2015 | June 30, 2026 | JENQ, ROBERT | reporter.nih.gov |
| The Hemodynamic and Metabolic Effects of Advanced Circulatory Support for Resuscitation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,211,098 | March 15, 2021 | February 28, 2026 | HALPERIN, HENRY R | reporter.nih.gov |
| Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | NIH | National Cancer Institute | 2021 to 2024 | $3,192,137 | April 1, 2020 | March 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Long-Term Islet Function and Impact after Total Pancreatectomy with Islet Autotransplant (LIFT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,185,530 | January 15, 2021 | December 31, 2026 | BELLIN, MELENA D. | reporter.nih.gov |
| CRISPR-Modified Cardiac Xenograft Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,182,820 | June 10, 2020 | May 31, 2025 | PIERSON, RICHARD N | reporter.nih.gov |
| Developing preclinical xenograft models in zebrafish. | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $3,178,512 | March 1, 2022 | February 28, 2026 | LANGENAU, DAVID MICHAEL | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Hematopoietic Stem Cell And Cord Blood Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,169,146 | September 30, 2005 | May 31, 2030 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Next Generation Therapies for Fertility Preservation in Male Cancer Patients | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,165,939 | May 15, 2020 | April 30, 2025 | ORWIG, KYLE EDWIN | reporter.nih.gov |
| Intrarenal B cells in acute kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,165,260 | February 15, 2020 | January 31, 2026 | CHONG, ANITA S | reporter.nih.gov |
| Ex Vivo Generation of Functional Kidney Tissues for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,161,308 | September 1, 2020 | May 14, 2025 | LEWIS, JENNIFER A. | reporter.nih.gov |
| Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,611 | December 15, 2021 | November 30, 2026 | VANDE GEEST, JONATHAN PIETER | reporter.nih.gov |
| Complement regulates macrophage and platelet function in kidney transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,127,980 | September 17, 2021 | August 31, 2026 | BALDWIN, WILLIAM M | reporter.nih.gov |
| Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,121,383 | August 15, 2022 | July 31, 2026 | YANIK, GREGORY A | reporter.nih.gov |
| Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,120,296 | August 1, 2021 | July 31, 2027 | HAHN, THERESA E | reporter.nih.gov |
| Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation. | NIH | National Cancer Institute | 2021 to 2025 | $3,119,515 | July 1, 2020 | June 30, 2027 | VINCENT, BENJAMIN G | reporter.nih.gov |
| Targeted immune therapies in heart transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,118,293 | February 1, 2023 | January 31, 2026 | ABDI, REZA | reporter.nih.gov |
| Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,117,523 | July 15, 2021 | April 30, 2027 | MYERS, KASIANI | reporter.nih.gov |
| Evaluation of the Mechanisms Underlying Induction and Maintenance Immunosuppression Impact on T Cell Function after Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,106,301 | July 16, 2025 | June 30, 2029 | SCHAENMAN, JOANNA M | reporter.nih.gov |
| Engineering T cells to Promote Islet Transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,102,316 | April 1, 2022 | March 31, 2027 | RILEY, JAMES L. | reporter.nih.gov |
| Engineered Immune Cells for T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,097,818 | April 1, 2022 | March 31, 2026 | MEYER, EVERETT | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease | NIH | National Cancer Institute | 2023 to 2025 | $3,096,663 | September 1, 2023 | August 31, 2028 | MARTINEZ, OLIVIA M | reporter.nih.gov |
| MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,089,138 | August 20, 2021 | June 30, 2025 | KRAITCHMAN, DARA L | reporter.nih.gov |
| Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,005 | December 1, 2021 | November 30, 2025 | FUJISAKI, JOJI | reporter.nih.gov |
| Anti-inflammatory Cell Based Repair of Intervertebral Disc Degeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,075,117 | September 1, 2021 | August 31, 2026 | CHAHINE, NADEEN O. | reporter.nih.gov |
| BIOLOGICAL EMBEDDING OF CONTEXTUAL FACTORS IN HUMAN STEM CELLS: IMPLICATIONS FOR POPULATION HEALTH DIFFERENCES | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,074,250 | September 26, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Donor nonclassical monocytes mediate primary graft dysfunction and remote organ injury following lung transplant surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,065,003 | January 1, 2019 | December 31, 2028 | BHARAT, ANKIT | reporter.nih.gov |
| NAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health Disparities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $3,050,402 | September 1, 2023 | June 30, 2028 | CERVANTES, LILIA | reporter.nih.gov |
| Beta-2 adrenergic signaling in immune homeostasis and reconstitution | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,048,780 | April 15, 2022 | March 31, 2027 | CAO, XUEFANG | reporter.nih.gov |
| Microengineering vascularized and innervated bone-like scaffolds as an alternative to autologous bone grafts | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,048,776 | August 1, 2021 | April 30, 2027 | BERTASSONI, LUIZ EDUARDO | reporter.nih.gov |
| Dynamic OCE with acoustic micro-tapping for in vivo monitoring of skin graft surgeries | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,043,548 | April 1, 2021 | March 31, 2027 | PELIVANOV, IVAN | reporter.nih.gov |
| Acute Antibody Mediated Kidney Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,037,635 | September 17, 2021 | August 31, 2026 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $3,026,491 | September 30, 2018 | August 31, 2024 | REX, TONIA S | reporter.nih.gov |
| The novel role of beta3 integrin in regulating alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,014,928 | February 14, 2022 | January 31, 2027 | ABDI, REZA | reporter.nih.gov |
| Mechanisms of alloantibody production following renal transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,014,441 | February 22, 2021 | January 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,009,446 | June 15, 2020 | May 31, 2026 | RIZI, RAHIM R | reporter.nih.gov |
| Commercialization Readiness for Bone Filler Scaffold Device to Aid in Dental Applications and Reconstruction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $3,006,953 | September 22, 2018 | August 31, 2024 | BALLARD, SHARON C | reporter.nih.gov |
| Generating Exogenic Organs for Transplantation without the Use of Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,005,890 | September 21, 2022 | July 31, 2027 | STEER, CLIFFORD JOHN | reporter.nih.gov |
| Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,004,032 | September 1, 2022 | June 30, 2026 | ROJAS-PENA, ALVARO | reporter.nih.gov |
| Personal tumor neoantigens for immunity against chronic lymphocytic leukemia | NIH | National Cancer Institute | 2022 to 2025 | $2,996,021 | June 1, 2011 | January 31, 2027 | WU, CATHERINE JU-YING | reporter.nih.gov |
| BiVACOR - A Physiological, Durable and Blood-Friendly Total Artificial Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,992,071 | September 1, 2017 | April 30, 2024 | TIMMS, DANIEL | reporter.nih.gov |
| Systematic identification of minor histocompatibility antigens to address GVHD | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,991,041 | April 1, 2022 | March 31, 2026 | KESKIN, DERIN B | reporter.nih.gov |
| i-AKC: Integrated AIRR Knowledge Commons | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,984,970 | August 1, 2023 | May 31, 2028 | COWELL, LINDSAY G. | reporter.nih.gov |
| Stem Cell and Transplantation Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,984,057 | August 1, 2015 | July 31, 2028 | STIREWALT, DEREK L | reporter.nih.gov |
| Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,973,070 | September 1, 2018 | December 1, 2024 | LOCKE, JAYME ELIZABETH | reporter.nih.gov |
| Integration and functionality of retinal organoid transplants | NIH | National Eye Institute | 2021 to 2025 | $2,971,351 | May 1, 2021 | March 31, 2027 | SEILER, MAGDALENE J | reporter.nih.gov |
| Photoabsorbing bioinks for expanding 3D printed human liver in situ | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,967,973 | September 21, 2021 | May 31, 2026 | STEVENS, KELLY R | reporter.nih.gov |
| Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,966,978 | December 1, 2021 | November 30, 2026 | CHENG, GUANG-SHING | reporter.nih.gov |
| Optimizing Lung Transplant Benefit Using Agent-Based Simulation Modeling Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,960,354 | June 1, 2020 | April 30, 2029 | VALAPOUR, MARYAM | reporter.nih.gov |
| Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,958,614 | June 1, 2020 | May 31, 2026 | GBADEGESIN, RASHEED ADEBAYO | reporter.nih.gov |
| MIDAS: MIcroangiopathy, endothelial Damage in Adults undergoing Stem cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,957,506 | August 20, 2020 | July 31, 2026 | VASU, SUMITHIRA | reporter.nih.gov |
| Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMVPreventionin D+R- Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,952,999 | July 12, 2024 | May 31, 2031 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| A critical role for macrophage ferroptosis in promoting fungal invasion in lung transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,952,966 | April 1, 2021 | March 31, 2027 | HSU, JOE L | reporter.nih.gov |
| Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,948,443 | August 6, 2021 | December 31, 2026 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,938,841 | May 10, 2022 | June 30, 2024 | KRAMS, SHERI M. | reporter.nih.gov |
| T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,927,774 | April 1, 2022 | March 31, 2027 | TOBIAN, AARON A | reporter.nih.gov |
| In utero gene editing to cure a metabolic liver disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,918,864 | February 1, 2020 | January 31, 2026 | PERANTEAU, WILLIAM H. | reporter.nih.gov |
| Retinal disease models for translational photoreceptor replacement | NIH | National Eye Institute | 2021 to 2022 | $2,898,123 | September 30, 2018 | May 31, 2025 | WOLFE, JOHN H | reporter.nih.gov |
| High subzero preservation of liver for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,898,028 | July 17, 2017 | December 31, 2025 | TONER, MEHMET | reporter.nih.gov |
| Immunogenomic analysis of donor lung injury and its impact on clinical outcomes after lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,897,255 | July 10, 2022 | June 30, 2027 | SHAVER, CIARA M | reporter.nih.gov |
| Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,886,575 | April 1, 2023 | January 31, 2027 | LINDMAN, BRIAN RICHARD | reporter.nih.gov |
| Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,871,936 | August 1, 2021 | July 31, 2027 | EGBE, ALEXANDER | reporter.nih.gov |
| Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,867,908 | June 1, 2020 | May 31, 2026 | WALLER, EDMUND K | reporter.nih.gov |
| WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,862,721 | September 10, 2021 | August 31, 2026 | LEE, BRENDAN | reporter.nih.gov |
| Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,861,908 | April 1, 2021 | March 31, 2026 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Determinants of T Cell Fate in Transplantation Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,859,856 | August 1, 2022 | July 31, 2027 | FORD, MANDY L | reporter.nih.gov |
| In Vivo Prevention of Murine GVHD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,859,522 | July 1, 2022 | June 30, 2027 | BLAZAR, BRUCE R | reporter.nih.gov |
| Quantitative Multiparametric MRI to Assess the Effect of Stem Cell Therapy on Chronic Low Back Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,858,064 | August 1, 2014 | July 31, 2025 | LI, DEBIAO | reporter.nih.gov |
| Molecular regulation of native hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,856,222 | February 15, 2016 | December 31, 2025 | CAMARGO, FERNANDO | reporter.nih.gov |
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,855,157 | May 1, 2020 | April 30, 2026 | KELLER, MICHAEL DANIEL | reporter.nih.gov |
| Wnt signaling in hematopoietic development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,849,578 | January 1, 2017 | June 30, 2025 | WILLERT, KARL H | reporter.nih.gov |
| Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,842,625 | July 15, 2022 | June 30, 2027 | WANG, BINGHE | reporter.nih.gov |
| Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers | NIH | National Cancer Institute | 2021 to 2025 | $2,839,105 | April 1, 2021 | March 31, 2027 | VINCI, CHRISTINE | reporter.nih.gov |
| Development of platforms for beta cell-specific delivery and ligand discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,837,648 | July 1, 2023 | June 30, 2027 | CHOUDHARY, AMIT | reporter.nih.gov |
| Developing gene therapy strategies to treat alpha thalassemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,821,947 | January 1, 2022 | December 31, 2025 | MACKENZIE, TIPPI | reporter.nih.gov |
| Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,817,305 | July 1, 2022 | April 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| Characterization of Renal Allograft Fibrosis and Prediction of Outcome Using a Quantitative MRI Approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,812,749 | July 8, 2021 | April 30, 2027 | LEWIS, SARA C | reporter.nih.gov |
| The role of the intestinal microbiome in cancer immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $2,811,009 | August 1, 2023 | July 31, 2030 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation | NIH | National Cancer Institute | 2022 to 2025 | $2,804,127 | July 22, 2022 | June 30, 2027 | VALDIMARSDOTTIR, HEIDDIS | reporter.nih.gov |
| Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,801,000 | September 20, 2018 | August 31, 2025 | SHEMESH, EYAL | reporter.nih.gov |
| Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,788,955 | May 4, 2022 | February 28, 2027 | SERPER, MARINA | reporter.nih.gov |
| Elastic, Degradable Vascular Grafts with Helical Microfibers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,787,042 | August 15, 2021 | July 31, 2025 | WANG, YADONG | reporter.nih.gov |
| Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $2,786,444 | August 1, 2018 | July 31, 2024 | PARK, JULIE R | reporter.nih.gov |
| Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,785,889 | February 1, 2020 | January 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,785,676 | May 15, 2022 | February 28, 2027 | KU, ELAINE | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Novel Biomarkers for Post-Liver Transplant NASH Fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,777,764 | July 18, 2022 | May 31, 2027 | ARTEEL, GAVIN E | reporter.nih.gov |
| Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patients’ induced pluripotent stem cells and genome editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,760,413 | May 1, 2020 | April 30, 2026 | YANG, BO | reporter.nih.gov |
| Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,758,516 | July 1, 2022 | June 30, 2027 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,754,807 | September 19, 2022 | June 30, 2027 | FARACH-CARSON, MARY C | reporter.nih.gov |
| Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors | NIH | National Cancer Institute | 2021 to 2025 | $2,750,972 | July 12, 2021 | June 30, 2027 | NGEN, ETHEL JOSO | reporter.nih.gov |
| Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,750,911 | May 19, 2022 | April 30, 2027 | SERPER, MARINA | reporter.nih.gov |
| In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,743,808 | January 10, 2023 | December 31, 2027 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Computational model-driven design to mitigate vein graft failure after coronary artery bypass | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,736,546 | August 15, 2022 | June 30, 2027 | MARSDEN, ALISON L | reporter.nih.gov |
| Conformal Total Body and Marrow Irradiation for Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,727,228 | September 13, 2011 | December 31, 2025 | HUI, SUSANTA K | reporter.nih.gov |
| Role of TRPV4 channel signaling in lung ischemia-reperfusion injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,714,601 | April 15, 2021 | March 31, 2026 | LAUBACH, VICTOR E | reporter.nih.gov |
| INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,713,953 | September 1, 2023 | June 30, 2028 | CHAN, LILI | reporter.nih.gov |
| Predictive modeling of acute rejection in pediatric heart transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,708,586 | July 15, 2022 | June 30, 2027 | SOSLOW, JONATHAN HARVEY | reporter.nih.gov |
| Ultrasonic Imaging of Bone Graft Healing in Extraction Sockets for Precise and Personalized Implant Therapy | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,707,757 | September 6, 2022 | August 31, 2026 | KRIPFGANS, OLIVER D | reporter.nih.gov |
| Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,705,917 | March 10, 2020 | February 28, 2026 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,702,674 | September 1, 2018 | January 31, 2029 | REED, ELAINE F | reporter.nih.gov |
| Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,694,538 | January 13, 2020 | December 31, 2025 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,690,675 | June 18, 2021 | April 30, 2027 | KENDRICK, JESSICA B | reporter.nih.gov |
| Clinical Significance of MHC Haplotypes in HCT | NIH | National Cancer Institute | 2021 to 2025 | $2,687,420 | March 1, 2003 | August 31, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Enhancing Innate Immune Reconstitution Post Allogeneic HSCT. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,685,463 | September 1, 2021 | June 30, 2025 | SERODY, JONATHAN S. | reporter.nih.gov |
| Computational and Experimental Modeling of Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,685,262 | January 1, 2022 | December 31, 2026 | GRIFFITH, BOYCE EUGENE | reporter.nih.gov |
| Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia. | NIH | National Cancer Institute | 2022 to 2025 | $2,677,641 | August 1, 2022 | July 31, 2027 | STIEGLITZ, ELLIOT | reporter.nih.gov |
| Immuno-Isolating capsule for delivery of cell-based therapy for restoration of ovarian endocrine function in an animal model | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,674,237 | August 15, 2022 | May 31, 2027 | SHIKANOV, ARIELLA | reporter.nih.gov |
| Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,671,817 | July 1, 2020 | June 30, 2026 | LASKIN, BENJAMIN LEWIS | reporter.nih.gov |
| Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,663,582 | February 15, 2021 | January 31, 2026 | BLAZAR, BRUCE R | reporter.nih.gov |
| Peptide-dependent mobilization of CD8 regulatory cells in cardiac transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,660,122 | August 21, 2023 | July 31, 2027 | AZZI, JAMIL | reporter.nih.gov |
| Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,653,376 | September 1, 2022 | July 31, 2027 | IACOMINI, JOHN J | reporter.nih.gov |
| Airway epithelial cell and lymphocyte interactions in chronic lung allograft dysfunction pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,652,554 | August 15, 2022 | July 31, 2027 | GREENLAND, JOHN | reporter.nih.gov |
| Improving Outcomes Assessment in Chronic Graft versus Host Disease | NIH | National Cancer Institute | 2022 to 2025 | $2,646,165 | July 18, 2007 | March 31, 2027 | LEE, STEPHANIE J | reporter.nih.gov |
| Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,636,174 | July 13, 2022 | April 30, 2027 | PARK, DONGSU | reporter.nih.gov |
| Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,635,227 | August 15, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Objective lung assessment tools for improved organ use in lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,625,302 | July 15, 2021 | August 31, 2025 | CANTU, EDWARD | reporter.nih.gov |
| Clinically Applicable Orofacial Cleft Reconstruction Using Structural, Compositional Biomimetic Bone Scaffolds | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,621,884 | August 1, 2022 | July 31, 2027 | LEE, SANG JIN | reporter.nih.gov |
| In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,618,613 | June 1, 2016 | July 31, 2025 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,608,764 | February 9, 2022 | November 30, 2026 | TRIVEDI, AMAL N. | reporter.nih.gov |
| Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,608,434 | May 15, 2020 | April 30, 2026 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Intravital analysis of hematopoietic stem cells in their bone marrow niche - Resubmission - 1 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,607,213 | September 20, 2021 | August 31, 2025 | REIZIS, BORIS | reporter.nih.gov |
| Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle loss | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,591,324 | March 1, 2021 | February 28, 2027 | SHIN, SU RYON | reporter.nih.gov |
| An Interneuron-based Cell Therapy for Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,589,602 | September 1, 2010 | March 31, 2027 | BARABAN, SCOTT C | reporter.nih.gov |
| Development of a stem-cell derived thymic cell therapy to treat patients with athymia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,586,728 | April 15, 2022 | January 31, 2027 | LIM, BING | reporter.nih.gov |
| Rectifying splicing mutations in blood disorders by gene editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,584,045 | December 20, 2019 | November 30, 2023 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Microribbon scaffold-mediated Immunomodulation for Cranial Bone Repair | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,582,020 | January 1, 2015 | May 31, 2027 | YANG, FAN | reporter.nih.gov |
| Chronic Antibody-Mediated Rejection of Kidney Allografts | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,566,057 | February 1, 2022 | January 31, 2027 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,563,053 | August 1, 2020 | July 31, 2025 | HUARD, JOHNNY | reporter.nih.gov |
| Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,560,634 | August 15, 2021 | July 31, 2025 | KAYLER, LIISE | reporter.nih.gov |
| Modulated release of anti-senescence drugs to stimulate aged bone repair | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,553,994 | June 1, 2012 | January 31, 2027 | KUHN, LIISA TIINA | reporter.nih.gov |
| Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,553,048 | February 15, 2023 | January 31, 2027 | ZENG, DEFU | reporter.nih.gov |
| Vascular networks genetically engineered for protein drug delivery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,552,882 | August 15, 2015 | April 30, 2026 | MELERO-MARTIN, JUAN M | reporter.nih.gov |
| Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,549,156 | September 30, 2020 | September 29, 2025 | STERN, JEFFREY H | reporter.nih.gov |
| Intestinal tissue intrinsic mechanisms in regulation of GI GVHD | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,544,373 | June 13, 2022 | May 31, 2027 | REDDY, PAVAN | reporter.nih.gov |
| Renal Anhydramnios Fetal Therapy (RAFT) Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,540,189 | April 1, 2020 | February 28, 2026 | ATKINSON, MEREDITH ANN | reporter.nih.gov |
| Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,529,105 | August 24, 2017 | July 31, 2024 | WAYNE, ALAN S. | reporter.nih.gov |
| Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,527,128 | September 20, 2016 | May 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| Promoting Increases in Living Organ Donation via Tele-navigation (PILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,523,913 | April 1, 2021 | February 28, 2026 | LOCKE, JAYME ELIZABETH | reporter.nih.gov |
| Drug-gene-nutraceutical interactions of cannabidiol | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $2,519,234 | February 22, 2022 | January 31, 2027 | EADON, MICHAEL THOMAS | reporter.nih.gov |
| Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney Viability | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,502,656 | September 15, 2022 | July 31, 2027 | ZHANG, XIAOHUI FRANK | reporter.nih.gov |
| Using a SMART Design to Optimize PTSD Symptom Management Strategies Among Cancer Survivors | NIH | National Cancer Institute | 2021 to 2024 | $2,482,100 | December 1, 2019 | November 30, 2025 | SMITH, SOPHIA K. | reporter.nih.gov |
| Trimodal Vitality Imaging of Neural Progenitor Cells in the Spinal Cord | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,476,665 | August 1, 2020 | April 30, 2027 | EMELIANOV, STANISLAV Y | reporter.nih.gov |
| Organ banking for transplant--kidney cryopreservation by vitrification and novel nanowarming technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,474,268 | April 13, 2018 | March 31, 2027 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $2,471,566 | July 1, 2021 | March 31, 2029 | UYGUN, KORKUT | reporter.nih.gov |
| Characterizing Emerging Humanized Immune Mouse Models for the study of transplant rejection and infectious disease pathology (Epstein Barr Virus) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,464,113 | February 2, 2021 | August 30, 2024 | BROWN, MATTHEW E | reporter.nih.gov |
| Mechanism of transplanted neonatal cardiac progenitor cells to repair ischemic myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,462,741 | April 20, 2014 | August 31, 2025 | SCHUMACKER, PAUL T | reporter.nih.gov |
| Identifying pathways required for integration of kidney organoid and host epithelia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,461,009 | September 1, 2020 | May 31, 2025 | DRUMMOND, IAIN A. | reporter.nih.gov |
| An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,460,707 | February 15, 2021 | January 31, 2027 | ZHAO, MINGTAO | reporter.nih.gov |
| Preservation of DCD Allograft Integrity for Liver Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,457,892 | January 13, 2020 | November 30, 2025 | BLACK, SYLVESTER M | reporter.nih.gov |
| Pathogenesis of Airway Stem Cell Abnormalities in Obliterative Bronchiolitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,452,366 | April 1, 2019 | January 31, 2029 | PAREKH, KALPAJ RAJNIKANT | reporter.nih.gov |
| Control of GVHD by Probiotics with individual Commensal Bacteria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,448,717 | May 5, 2022 | April 30, 2027 | YU, XUE-ZHONG | reporter.nih.gov |
| A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,446,598 | July 1, 2023 | April 30, 2028 | JANG, HAE LIN | reporter.nih.gov |
| Improving Access to Nephrology Treatment and Care among Patients at Greatest Risk for Kidney Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,442,134 | September 1, 2023 | June 30, 2028 | ARRIOLA, KIMBERLY RUTH JACOB | reporter.nih.gov |
| Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,439,463 | August 1, 2012 | April 30, 2024 | KAUFMAN, DIXON B | reporter.nih.gov |
| Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,438,515 | January 5, 2021 | December 31, 2025 | HSU, KATHARINE C | reporter.nih.gov |
| Post-Transplant Inflammatory Response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,437,884 | April 1, 1997 | November 30, 2029 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| BMP2 Regulation of Periosteal Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,436,018 | August 1, 2020 | April 30, 2026 | ROSEN, VICKI | reporter.nih.gov |
| Stem cells for therapeutics discovery in genetic blood disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,429,809 | September 23, 2016 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Immunoregulatory Mechanisms of IL-33 in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,429,537 | August 10, 2022 | June 30, 2027 | TURNQUIST, HETH R | reporter.nih.gov |
| Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,428,878 | September 12, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| In vivo Monitoring of Neutrophil Function in Patients after Stem Cell Transplant | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,426,537 | February 13, 2023 | January 31, 2028 | IRIMIA, DANIEL | reporter.nih.gov |
| Allorecognition, parasitic stem cells and regeneration in a basal chordate | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,424,717 | January 1, 2021 | December 31, 2026 | DE TOMASO, ANTHONY W | reporter.nih.gov |
| High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,415,000 | September 30, 2021 | July 31, 2027 | WESSELY, OLIVER | reporter.nih.gov |
| Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,414,163 | February 1, 2019 | January 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| New approaches to kidney banking through nature-inspired high sub-zero preservation strategies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,410,750 | August 5, 2019 | August 31, 2026 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Control of dysfunctional Tregs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,407,966 | February 1, 2014 | January 31, 2027 | LI, XIAN CHANG | reporter.nih.gov |
| SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,406,599 | May 1, 2022 | January 31, 2026 | ANDERSON, DANIEL G | reporter.nih.gov |
| Designing induction therapies to target memory T cells in high risk recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,405,990 | July 15, 2014 | August 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,399,982 | August 17, 2023 | July 31, 2027 | TAMBUR, ANAT R. | reporter.nih.gov |
| Continuation of The Collaborative Islet Transplantation Registry (CITR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,074 | September 15, 2022 | June 30, 2027 | PAYNE, ELIZABETH HOLLY | reporter.nih.gov |
| Targeting heat shock protein 72 to improve renal function after transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,394,886 | March 15, 2021 | July 31, 2026 | PARAJULI, NIRMALA | reporter.nih.gov |
| Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,392,495 | March 1, 2021 | January 31, 2027 | NAYAK, JAYAKAR V | reporter.nih.gov |
| Promoting T cell reconstitution after hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,391,092 | January 1, 2024 | December 31, 2030 | DUDAKOV, JARROD | reporter.nih.gov |
| Scalable and transplantable pancreatic islet organoids with engineered oxygenation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,390,830 | September 1, 2025 | August 31, 2029 | KOMATSU, HIROTAKE | reporter.nih.gov |
| HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,390,244 | January 13, 2023 | December 31, 2026 | HENRICH, TIMOTHY JENSEN | reporter.nih.gov |
| Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,388,592 | September 21, 2016 | May 31, 2025 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Development of heparan sulfate-based therapeutics to treat inflammatory diseases | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,387,583 | September 14, 2021 | July 31, 2026 | WANG, ZHANGJIE | reporter.nih.gov |
| Virtually Supervised Exercise for Kidney Transplant Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,386,134 | September 15, 2022 | August 31, 2027 | LIU, CHRISTINE KEE | reporter.nih.gov |
| Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,385,337 | September 18, 2020 | August 31, 2025 | TONG, WEI | reporter.nih.gov |
| Access to Kidney Transplantation in Minority Populations (AKT-MP) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,384,015 | July 7, 2020 | January 31, 2026 | MYASKOVSKY, LARISSA | reporter.nih.gov |
| Small molecule therapeutic for calcific aortic valve disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,378,349 | August 1, 2023 | May 31, 2027 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,378,023 | February 6, 2023 | January 31, 2028 | KWUN, JEAN | reporter.nih.gov |
| Trillion cell culture to fuel organ biofabrication | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,361,000 | September 1, 2022 | August 31, 2027 | SKYLAR-SCOTT, MARK A. | reporter.nih.gov |
| CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,357,715 | September 22, 2022 | August 31, 2027 | BONGARZONE, ERNESTO ROQUE | reporter.nih.gov |
| In Vivo Detection And Mechanisms of Regulatory B cell Function in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,357,214 | July 1, 2015 | March 31, 2027 | ROTHSTEIN, DAVID M | reporter.nih.gov |
| Immunosuppression-free transplantation through placental mimicry | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,355,000 | September 14, 2021 | August 31, 2026 | WEAVER, JESSICA DIANE | reporter.nih.gov |
| Multipotent ABCB5-positive cell therapeutics for corneal disease | NIH | National Eye Institute | 2021 to 2022 | $2,352,662 | April 1, 2018 | January 31, 2024 | FRANK, NATASHA Y | reporter.nih.gov |
| 3D Bioprinted Spinal Cord Organoids as a Relay System for Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,352,214 | September 2, 2021 | June 30, 2026 | PARR, ANN M | reporter.nih.gov |
| Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,346,523 | May 1, 2021 | April 30, 2027 | KOGUT, IGOR | reporter.nih.gov |
| Outcomes in living kidney donors over 50 years compared to a healthy matched contemporaneous non-donor cohort from the same geographical region | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,341,803 | July 1, 2020 | April 30, 2025 | MATAS, ARTHUR J | reporter.nih.gov |
| Retinal sheet transplant impact on functional organization of visual cortex in retinal degenerate animal models | NIH | National Eye Institute | 2022 to 2025 | $2,340,862 | May 1, 2022 | March 31, 2027 | LYON, DAVID C | reporter.nih.gov |
| HLA Immunogenetics and kidney allograft outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,883 | November 21, 2022 | October 31, 2027 | KAMOUN, MALEK | reporter.nih.gov |
| Molecular basis and protective efficacy of cross-neutralizing antibodies against four major respiratory viruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,206 | March 16, 2023 | February 29, 2028 | BOONYARATANAKORNKIT, JIM | reporter.nih.gov |
| Computer-Assisted Histologic Evaluation of Cardiac Allograft Rejection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,335,528 | September 1, 2020 | August 31, 2025 | MARGULIES, KENNETH BER | reporter.nih.gov |
| The Synthetic Kidney: A Revolutionary Solution for the Shortage of Kidneys for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,335,138 | September 15, 2022 | August 31, 2027 | LI, ZHONGWEI | reporter.nih.gov |
| Lymph Node Delivery in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,334,750 | June 18, 2022 | May 31, 2027 | ABDI, REZA | reporter.nih.gov |
| Chemotherapy-free cure of hemoglobin disorders through base editing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,334,252 | September 1, 2023 | May 31, 2027 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Integrated Cellular and Tissue Engineering for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,333,316 | September 15, 2016 | May 31, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,331,970 | August 20, 2020 | July 31, 2025 | HUNT, PETER W | reporter.nih.gov |
| Role of Brain Macrophages in the Pathogenesis and Treatment of Globoid Cell Leukodystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,327,864 | May 3, 2021 | March 31, 2027 | BENNETT, FREDERICK | reporter.nih.gov |
| Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,325,780 | April 20, 2021 | March 31, 2026 | SHLOMCHIK, WARREN D | reporter.nih.gov |
| ABCB5-positive stem cells for LSCD therapy | NIH | National Eye Institute | 2023 to 2025 | $2,325,074 | June 1, 2016 | May 31, 2028 | FRANK, MARKUS H. | reporter.nih.gov |
| Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development | NIH | National Cancer Institute | 2021 to 2024 | $2,319,039 | September 1, 2020 | August 31, 2025 | SLINGERLAND, JOYCE MARIE | reporter.nih.gov |
| Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality | NIH | National Cancer Institute | 2021 to 2024 | $2,315,110 | September 3, 2018 | January 31, 2026 | SORROR, MOHAMED | reporter.nih.gov |
| Derivation of pancreatic islet-like organoids from human gastric stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,313,256 | August 24, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| Biologic correlatives of chronic GVHD onset | NIH | National Cancer Institute | 2021 to 2023 | $2,309,532 | July 2, 2019 | June 30, 2025 | LEE, STEPHANIE J | reporter.nih.gov |
| The Impact of Structural Racism on Racial/Ethnic Disparities in End-Stage Kidney Disease from Healthy Population to Mortality | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,304,849 | August 1, 2022 | April 29, 2025 | DAW, JONATHAN KYLE | reporter.nih.gov |
| IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,303,969 | January 1, 2022 | June 30, 2026 | PACZESNY, SOPHIE | reporter.nih.gov |
| Transplantation of MHC Homozygous Vascular Progenitors in Primates | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,302,970 | September 20, 2016 | May 31, 2025 | SLUKVIN, IGOR I. | reporter.nih.gov |
| The impact of upper gastrointestinal dysmotility on aspiration-associated aerodigestive disorders in children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,300,603 | July 1, 2015 | May 31, 2027 | ROSEN, RACHEL L | reporter.nih.gov |
| T cell invasion of the stem cell compartment during immune-mediated GI damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,846 | January 1, 2021 | December 31, 2025 | HANASH, ALAN M | reporter.nih.gov |
| Engineering optimization and scaling enables high quality pancreatic islet cryopreservation for banking and transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,294,596 | September 22, 2021 | July 31, 2025 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Multi-omic Biomarker Discovery and Validation in Heart Transplant Patient Populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,294,125 | March 1, 2020 | June 30, 2023 | KEATING, BRENDAN JAMES | reporter.nih.gov |
| Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,291,761 | July 15, 2022 | June 30, 2027 | GETZ, KELLY DIRINGER | reporter.nih.gov |
| Understanding and targeting bone marrow microenvironment in myelofibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,288,703 | January 1, 2021 | December 31, 2025 | DING, LEI | reporter.nih.gov |
| HuR/HIF – SIRT1 Signaling Axis in Liver Transplant Rejuvenation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,287,369 | April 1, 2003 | March 31, 2027 | KUPIEC-WEGLINSKI, JERZY W | reporter.nih.gov |
| Biomechanical Determinants of Hematopoietic Stem Cell Potential | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,282,783 | January 15, 2018 | November 30, 2026 | WENZEL, PAMELA LYNN | reporter.nih.gov |
| The Role of Donor-Derived Eosinophils on Lung Allograft Ischemia Reperfusion Injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,276,035 | February 1, 2019 | August 31, 2030 | KRUPNICK, ALEXANDER S. | reporter.nih.gov |
| IRI, innate immunity and transplant rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,266,791 | March 15, 2021 | February 28, 2026 | ABDI, REZA | reporter.nih.gov |
| Tapeworm stem cells as drivers of regeneration and reproduction | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,265,000 | March 5, 2021 | February 28, 2027 | ROZARIO, TANIA | reporter.nih.gov |
| Liver Xenotransplantation using CRISPR-modified Porcine Organs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,264,625 | February 1, 2020 | December 1, 2023 | MARKMANN, JAMES FRANCIS | reporter.nih.gov |
| High resolution lineage tracing of developmental hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,256,385 | May 5, 2023 | February 28, 2027 | CAMARGO, FERNANDO | reporter.nih.gov |
| Preparation for lung transplant discussions and decisions among people with cystic fibrosis | NIH | National Institute of Nursing Research | 2023 to 2025 | $2,255,861 | April 19, 2023 | January 31, 2028 | RAMOS, KATHLEEN JESSICA | reporter.nih.gov |
| Genetic Testing (APOL1) Decisional Support for Potential Living Kidney Donors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,255,854 | September 30, 2021 | April 30, 2026 | GARDINER, HEATHER MARIE | reporter.nih.gov |
| A stem cell activated cryogel bioscaffold that restores islet bioenergetics while providing oxygen and nutrients at extravascular sites of transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,251,861 | April 1, 2022 | March 31, 2027 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Elution of a Small Molecule from a Bio Ceramic Collagen Bone Graft Device Heals Bone while InhibitingBreast Cancer Bone Metastases | NIH | National Cancer Institute | 2021 to 2022 | $2,249,777 | November 30, 2021 | August 31, 2022 | MARGULIES, BRYAN SAMUEL | reporter.nih.gov |
| The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,249,248 | August 5, 2022 | July 31, 2027 | SINGER, JONATHAN PAUL | reporter.nih.gov |
| Culture-free pathogen tracking in hospitalized patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,245,086 | April 3, 2020 | March 31, 2025 | BHATT, AMI SIDDHARTH | reporter.nih.gov |
| Defining Protective CMV Immunity after Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,244,070 | February 6, 2023 | January 31, 2028 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Blockade of IL-23 for the Prevention of Graft Versus Host Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,237,924 | April 15, 2021 | March 31, 2026 | DROBYSKI, WILLIAM R. | reporter.nih.gov |
| Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,227,502 | January 1, 2020 | December 31, 2025 | OZBOLAT, IBRAHIM | reporter.nih.gov |
| Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,224,558 | August 1, 2015 | November 30, 2027 | DROBYSKI, WILLIAM R. | reporter.nih.gov |
| Viral and immune kinetics in rhinovirus infection following hematopoietic cell transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,222,417 | June 4, 2020 | May 31, 2025 | WAGHMARE, ALPANA AMALKANT | reporter.nih.gov |
| Tissue resident memory T cells and chronic lung allograft dysfunction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,220,732 | July 20, 2023 | April 30, 2028 | SNYDER, MARK EUGENE | reporter.nih.gov |
| Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,218,334 | January 17, 2017 | December 31, 2025 | KIEM, HANS-PETER | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,216,262 | September 22, 2023 | July 31, 2027 | BELLIN, MELENA D. | reporter.nih.gov |
| Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,213,082 | July 15, 2023 | April 30, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| Lung transplant injury drives chronic lung allograft dysfunction via recruitment ofmonocyte-derived alveolar macrophages | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,211,115 | September 1, 2020 | August 31, 2024 | MISHARIN, ALEXANDER | reporter.nih.gov |
| Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,206,197 | December 20, 2020 | November 30, 2024 | MELERO-MARTIN, JUAN M | reporter.nih.gov |
| Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,201,102 | July 1, 2023 | April 30, 2027 | WERTHEIM, JASON A | reporter.nih.gov |
| Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,196,794 | January 1, 2023 | November 30, 2026 | ZHU, WUQIANG | reporter.nih.gov |
| Rewiring the Injured Brain with GABA Progenitors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,163,757 | February 15, 2016 | March 31, 2027 | HUNT, ROBERT F | reporter.nih.gov |
| Using human skin grafted mice to identify biomarkers of exposure and study effects of radiation on skin | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,157,978 | February 21, 2020 | January 31, 2025 | CLARK, RACHAEL ANN | reporter.nih.gov |
| Complement-Mediated Exosome Function in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,152,526 | September 22, 2022 | July 31, 2027 | CHUN, NICHOLAS | reporter.nih.gov |
| Innate Allorecognition in Clinical Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,152,469 | December 20, 2022 | June 30, 2025 | LAKKIS, FADI G. | reporter.nih.gov |
| Mechanisms of accelerated calcification and structural degeneration of implantable biomaterials in pediatric cardiac surgery | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,151,713 | April 1, 2023 | January 31, 2027 | FERRARI, GIOVANNI | reporter.nih.gov |
| Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,149,845 | August 13, 2024 | May 31, 2029 | AULETTA, JEFFERY J | reporter.nih.gov |
| Long Term Oral Health Outcomes in the Chronic GVHD Consortium | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $2,148,169 | August 1, 2019 | July 31, 2025 | TREISTER, NATHANIEL S | reporter.nih.gov |
| Discriminating EGFR function in T cells and epithelium during immune-mediated tissue damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,147,877 | August 25, 2018 | June 30, 2028 | HANASH, ALAN M | reporter.nih.gov |
| Immunogenicity of Human Stem Cell-Derived Beta Cells and Muscle Cells in Humanized Mice | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $2,147,498 | August 15, 2019 | July 31, 2024 | GREINER, DALE LESLIE | reporter.nih.gov |
| Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,144,831 | July 19, 2023 | June 30, 2028 | REED, ELAINE F | reporter.nih.gov |
| Vascular Regeneration with Direct Reprogramming and Engineering Strategies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,143,183 | August 1, 2022 | July 31, 2026 | YOON, YOUNG-SUP | reporter.nih.gov |
| Non-APOL1 genetic factors and kidney transplant outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,142,442 | August 15, 2023 | May 31, 2028 | KIRYLUK, KRZYSZTOF | reporter.nih.gov |
| Readily Available Stem Cell-Based Vascular Grafts for Emergent Surgical Care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,141,117 | July 1, 2020 | June 30, 2025 | QYANG, YIBING | reporter.nih.gov |
| Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection | NIH | National Cancer Institute | 2021 to 2024 | $2,139,039 | April 1, 2020 | March 31, 2026 | AGOPIAN, VATCHE | reporter.nih.gov |
| Cell adhesion and tissue dynamics in the skin | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,136,170 | December 1, 1980 | August 31, 2028 | FUCHS, ELAINE | reporter.nih.gov |
| Machine Learning to identify Biomarkers for Risk of Chronic Graft-Versus-Host Disease | NIH | National Cancer Institute | 2022 to 2025 | $2,133,819 | December 2, 2021 | November 30, 2026 | PACZESNY, SOPHIE | reporter.nih.gov |
| The Role of Telomeres in Lung Transplant Recipient Immunity and Outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,129,020 | March 5, 2023 | February 29, 2028 | MCDYER, JOHN F | reporter.nih.gov |
| Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,124,583 | September 3, 2020 | May 31, 2027 | ZHANG, XINPING | reporter.nih.gov |
| Mechanisms controlling epicardial-dependent promotion of heart regeneration in zebrafish. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,118,750 | July 5, 2021 | June 30, 2027 | CAO, JINGLI | reporter.nih.gov |
| Curation of genetic defects causing combined immunodeficiency and infections in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,115,359 | July 1, 2021 | June 30, 2028 | CHINN, IVAN KINGYUE | reporter.nih.gov |
| Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,115,146 | August 1, 2020 | June 30, 2025 | FRAZIER, O. H. | reporter.nih.gov |
| Investigating hematopoietic stem cell dysfunction during sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,111,564 | April 1, 2023 | March 31, 2027 | MCKINNEY-FREEMAN, SHANNON L | reporter.nih.gov |
| Engineering synthetic cellular crosstalk for transplantation tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,109,666 | February 1, 2022 | January 31, 2027 | MA, LEYUAN | reporter.nih.gov |
| Non-Invasive Venous waveform Analysis (NIVA) for Monitoring Volume Status in Heart Failure Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,103,997 | August 1, 2019 | June 30, 2029 | ALVIS, BRET D. | reporter.nih.gov |
| Role of Eosinophils in Hepatic Ischemia Reperfusion Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,103,519 | June 1, 2019 | March 31, 2027 | JU, CYNTHIA | reporter.nih.gov |
| A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,102,265 | April 1, 2022 | March 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Mechanistic Inflammatory Pathways in Graft Versus Host Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,100,486 | August 1, 2020 | May 31, 2026 | DROBYSKI, WILLIAM R. | reporter.nih.gov |
| High subzero heart preservation: from zebrafish to mammals | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,100,000 | April 1, 2021 | March 31, 2027 | TESSIER, SHANNON NOELLA | reporter.nih.gov |
| Skeletal Muscle Regeneration from Pluripotent Stem Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,097,940 | June 1, 2021 | May 31, 2027 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Immuno and Epigenetics of Hematopoietic Cell Transplantation | NIH | National Cancer Institute | 2021 to 2025 | $2,093,460 | August 1, 2017 | April 30, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Local immune modulation for beta cell replacement therapy in type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,091,787 | April 1, 2022 | December 31, 2026 | PHELPS, EDWARD | reporter.nih.gov |
| Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,085,721 | September 11, 2019 | June 30, 2025 | KU, ELAINE | reporter.nih.gov |
| Vitamin D Deficiency, Insulin Resistance and Cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,078,647 | April 15, 2010 | March 31, 2027 | BERNAL-MIZRACHI, CARLOS | reporter.nih.gov |
| Lacrimal Gland Repair Using Progenitor Cells | NIH | National Eye Institute | 2021 to 2025 | $2,077,504 | January 1, 2016 | June 30, 2027 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| A place-based approach to geographic disparities in lung transplant | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,075,369 | August 1, 2023 | May 31, 2028 | TSUANG, WAYNE M | reporter.nih.gov |
| PET Tracer for Imaging of Lung Inflammation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,072,841 | September 1, 2023 | May 31, 2027 | SHARMA, VIJAY | reporter.nih.gov |
| Reduction of bloodstream infections from oral organisms in pediatric stem cell transplant: a randomized multicenter double-blind placebo-controlled study evaluating twice daily oral xylitol | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,064,644 | September 1, 2022 | August 31, 2027 | DANDOY, CHRISTOPHER EUGENE | reporter.nih.gov |
| Human iPSC-Based Personalized Cell Therapy of PD | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,062,628 | July 1, 2023 | April 30, 2028 | KIM, KWANG-SOO | reporter.nih.gov |
| Dissecting the role of dynamic epigenome prompting pathways leading to kidney allograft fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,062,322 | July 1, 2019 | June 30, 2025 | MAS, VALERIA RAQUEL | reporter.nih.gov |
| Deciphering unintended large gene modifications in gene editing for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,057,558 | July 1, 2023 | June 30, 2027 | BAO, GANG | reporter.nih.gov |
| BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,054,178 | September 17, 2021 | July 31, 2026 | GARCIA, ANDRES J | reporter.nih.gov |
| Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,054,144 | August 15, 2012 | November 30, 2026 | PARIKH, CHIRAG R | reporter.nih.gov |
| Early detection of pulmonary complications of hematopoietic stem-cell transplantation in children using hyperpolarized xenon MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,049,864 | February 15, 2023 | December 31, 2027 | WALKUP, LAURA LEE | reporter.nih.gov |
| Long-acting injectable tacrolimus for chronic immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $2,047,614 | July 8, 2022 | June 30, 2025 | SMITH, THOMAS J. | reporter.nih.gov |
| The Biological Consequences of Age-related Clonal Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,046,875 | February 10, 2021 | January 31, 2027 | GONDEK, LUKASZ PAWEL | reporter.nih.gov |
| Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD | NIH | National Cancer Institute | 2021 to 2025 | $2,045,952 | April 5, 2021 | March 31, 2027 | CHOE, HANNAH | reporter.nih.gov |
| Bioengineering Cornea with Autologous Stem Cells | NIH | National Eye Institute | 2022 to 2025 | $2,045,272 | May 1, 2016 | March 31, 2027 | FEINBERG, ADAM WALTER | reporter.nih.gov |
| Targeted conditioning to maximize prenatal HSC engraftment for SCD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,044,659 | July 1, 2023 | June 30, 2027 | ALMEIDA-PORADA, GRACA DUARTE | reporter.nih.gov |
| Neuropilin-2 in Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,036,192 | March 1, 2020 | February 28, 2026 | BRISCOE, DAVID M. | reporter.nih.gov |
| Embryonic vascular stem-progenitors for treatment of ischemic retinopathies | NIH | National Eye Institute | 2021 to 2024 | $2,033,849 | February 1, 2021 | January 31, 2026 | ZAMBIDIS, ELIAS T. | reporter.nih.gov |
| A first in class, mechanism-guided, cell-based therapy for complex regional pain syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $2,033,135 | September 24, 2022 | August 31, 2025 | CHENG, JIANGUO | reporter.nih.gov |
| Chronic Versus Acute Transplantation of Neural Tissues for TBI-Induced Cortical Injuries | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,031,527 | July 1, 2021 | June 30, 2027 | CHEN, HAN-CHIAO ISAAC | reporter.nih.gov |
| Notch Signaling in Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,031,145 | April 22, 2011 | May 31, 2027 | PEAR, WARREN S | reporter.nih.gov |
| Senescent cells drive mt-DNA accumulation and inflamm-aging | NIH | National Institute on Aging | 2021 to 2024 | $2,028,164 | June 15, 2020 | April 30, 2026 | TULLIUS, STEFAN GUNTHER | reporter.nih.gov |
| Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,027,511 | September 15, 2018 | August 31, 2023 | SAFDAR, NASIA | reporter.nih.gov |
| Optimizing HCT Outcomes: A Multi-omic Investigation | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,024,340 | August 15, 2025 | May 31, 2030 | KEAN, LESLIE S | reporter.nih.gov |
| The role of GSK3/PPAR-/mitophagy pathway in regulating hematopoia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,023,914 | January 1, 2022 | December 31, 2025 | HUANG, JIAN | reporter.nih.gov |
| Synthetic Mesenchymal Stem Cell Niches for Vascular Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,023,009 | August 15, 2013 | July 31, 2025 | TAN, WEI | reporter.nih.gov |
| Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,022,974 | December 17, 2022 | November 30, 2027 | MASSIE, ALLAN B | reporter.nih.gov |
| Length-dependent activation in human myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,020,753 | September 15, 2020 | July 31, 2025 | CAMPBELL, KENNETH S | reporter.nih.gov |
| Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,018,635 | February 28, 2020 | January 31, 2026 | POBER, JORDAN S | reporter.nih.gov |
| Corneal Scar Repair through SPAACKL: Sutureless, Pro-regenerative Anterior Additive Collagen gel KeratopLasty | NIH | National Eye Institute | 2022 to 2025 | $2,017,989 | March 1, 2022 | December 31, 2026 | MYUNG, DAVID | reporter.nih.gov |
| Exosome educated monocytes for acute radiation syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,007,828 | August 1, 2021 | July 31, 2025 | CAPITINI, CHRISTIAN | reporter.nih.gov |
| Multiplexed rapid immunoassay for invasive fungal disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,004,963 | September 23, 2020 | August 31, 2025 | KOZEL, THOMAS R | reporter.nih.gov |
| The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,004,858 | July 12, 2023 | June 30, 2028 | AZZI, JAMIL | reporter.nih.gov |
| PHMB-Impregnated Acellular Biologic Grafts for Treatment of Third-Degree Burns | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $2,004,706 | January 18, 2021 | August 31, 2025 | BLUM, JULIANA LYN | reporter.nih.gov |
| A Bullet Proof vascular graft to prevent dialysis access cannulation injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,999,167 | September 1, 2016 | June 30, 2023 | KNIGHT, JOSEPH | reporter.nih.gov |
| Cell adhesion-dependent mechanisms of beta cell growth and homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,998,151 | April 1, 2020 | February 28, 2025 | CIRULLI, VINCENZINO | reporter.nih.gov |
| HCMV Therapeutic Antibody Safety Trial | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,996,288 | July 1, 2020 | June 30, 2025 | KAUVAR, LAWRENCE MICHAEL | reporter.nih.gov |
| Development of a Novel Bone Adhesive Scaffold to Accelerate Bone Regeneration and Improve Ridge Height Maintenance for the Treatment of Patients with Residual Ridge Resorption | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2024 | $1,995,660 | June 1, 2023 | May 31, 2025 | JADIA, RAHUL | reporter.nih.gov |
| Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant | NIH | National Cancer Institute | 2023 to 2025 | $1,994,514 | August 10, 2023 | July 31, 2026 | VERA, JUAN FERNANDO | reporter.nih.gov |
| Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $1,992,855 | September 13, 2019 | August 31, 2025 | BAICU, SIMONA C | reporter.nih.gov |
| Engineering an immuno-isolating hydrogel for restoring ovarian endocrine function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,991,992 | September 30, 2016 | February 28, 2026 | SHIKANOV, ARIELLA | reporter.nih.gov |
| Neonatal and Young Pediatric Kidney Preservation through Nanowarming and Vitrification | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,991,119 | September 14, 2018 | June 30, 2027 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Automated System for High Yield Pancreatic Islet Isolation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,990,375 | September 15, 2017 | March 31, 2025 | HUANG, LOTIEN RICHARD | reporter.nih.gov |
| Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants | NIH | National Eye Institute | 2021 to 2025 | $1,990,241 | April 1, 2020 | February 28, 2030 | LEVY, ROBERT BENJAMIN | reporter.nih.gov |
| Single-cell RNA sequencing reveals novel regulatory pathways in maintaining limbal epithelial stem cell homeostasis | NIH | National Eye Institute | 2021 to 2025 | $1,988,000 | September 1, 2021 | July 31, 2026 | PENG, HAN | reporter.nih.gov |
| Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,986,927 | August 1, 2023 | May 31, 2026 | KLINE, MARK A | reporter.nih.gov |
| Developing photoreceptor repair for macular degeneration therapy. | NIH | National Eye Institute | 2021 to 2025 | $1,986,308 | September 30, 2021 | July 31, 2026 | SINGH, MANDEEP | reporter.nih.gov |
| Transcriptional Regulation of Endothelial Cells after Neonatal Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,984,340 | April 1, 2018 | June 30, 2027 | KALINICHENKO, VLADIMIR | reporter.nih.gov |
| Metabolic regulation of stem cell niche development and function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,984,032 | July 1, 2022 | May 31, 2026 | QU, CHENG-KUI | reporter.nih.gov |
| Scaffolds with high oxygen content for mineralization | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $1,982,762 | August 1, 2021 | July 31, 2027 | CAMCI-UNAL, GULDEN | reporter.nih.gov |
| Embryonic Stem Cell Therapy after Cervical Contusion SCI in NHPs | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,982,569 | February 1, 2023 | January 31, 2028 | ROSENZWEIG, EPHRON SOLOMON | reporter.nih.gov |
| Improving marginal allograft outcomes through cell junction stabilization in transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,981,284 | April 15, 2020 | March 31, 2024 | GREK, CHRISTINA | reporter.nih.gov |
| InflammaGut: a drug-screenable co-culture system using gut-associated lymphocytes and autologous primary human gut epithelium that reports inflammation | NIH | National Center for Advancing Translational Sciences | 2022 to 2023 | $1,980,716 | May 1, 2022 | January 31, 2025 | THELIN, BILL | reporter.nih.gov |
| Translating Novel Peripheral Nerve Allograft Technologies Toward Clinical Use | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,980,377 | May 1, 2023 | April 30, 2027 | BITTNER, GEORGE DAVIS | reporter.nih.gov |
| Delirium in Children Undergoing Hematopoietic Stem Cell Transplants | NIH | National Cancer Institute | 2021 to 2024 | $1,975,976 | September 1, 2020 | May 31, 2026 | TRAUBE, CHANI | reporter.nih.gov |
| A recombinant matrix to improve autologous tissue grafts | NIH | National Cancer Institute | 2022 to 2023 | $1,972,696 | September 11, 2019 | June 30, 2025 | ROBERTS, STEFAN | reporter.nih.gov |
| Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,972,069 | September 30, 2020 | August 31, 2025 | FARMER, DIANA LEE | reporter.nih.gov |
| Human Dopamine Grafts in Alpha-Synuclein Models of Parkinson Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,967,447 | July 1, 2023 | June 30, 2028 | TABAR, VIVIANE | reporter.nih.gov |
| Racial disparities in access to kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,967,199 | December 6, 2017 | March 31, 2029 | KU, ELAINE | reporter.nih.gov |
| Development of platforms for sorting, production, editing of beta cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,966,825 | September 5, 2023 | April 30, 2028 | CHOUDHARY, AMIT | reporter.nih.gov |
| Choriocapillaris Protection and Replacement in AMD | NIH | National Eye Institute | 2021 to 2025 | $1,966,287 | August 1, 2014 | December 31, 2027 | MULLINS, ROBERT FOSTER | reporter.nih.gov |
| Urgent and unmet need for a long-term solution for increasing pediatric heart-failure population: BiVACOR Rotary Total Artificial Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,965,590 | August 5, 2021 | July 31, 2025 | TIMMS, DANIEL | reporter.nih.gov |
| Isochoric Pressure Based Preservation of Ovarian Tissue | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,958,572 | September 26, 2016 | September 30, 2023 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,957,180 | August 1, 2023 | July 31, 2027 | TANG, PAUL | reporter.nih.gov |
| Vascular Regeneration with Human Pluripotent Stem Cell-derived Vascular Cells and Engineering Approaches | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,956,185 | January 15, 2022 | December 31, 2025 | YOON, YOUNG-SUP | reporter.nih.gov |
| Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation | NIH | National Cancer Institute | 2023 to 2025 | $1,953,422 | May 2, 2023 | April 30, 2028 | DIAMOND, DON J | reporter.nih.gov |
| Tumor matrix remodeling in anti-myeloma immunity and immunotherapy | NIH | National Cancer Institute | 2021 to 2024 | $1,950,659 | July 1, 2020 | December 31, 2024 | ASIMAKOPOULOS, FOTIOS | reporter.nih.gov |
| DOT1L, reconstitution of plasmacytoid dendritic cells and alloimmunity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,948,900 | November 23, 2021 | March 31, 2026 | ZHANG, YI | reporter.nih.gov |
| VisR Ultrasound for Monitoring Antibody-Mediated Rejection in Renal Transplant Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,948,258 | March 1, 2016 | November 30, 2027 | GALLIPPI, CATERINA M | reporter.nih.gov |
| Conformal islet encapsulation for transplantation at vascularized sites to allow physiological insulin secretion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,946,597 | July 5, 2016 | February 28, 2029 | TOMEI, ALICE | reporter.nih.gov |
| Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,946,161 | September 17, 2024 | June 30, 2027 | TAYLOR, MICHAEL JOHN | reporter.nih.gov |
| Microbiota Regulation of Pulmonary Complications Post-HCT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,941,600 | September 20, 2021 | August 31, 2026 | ZHOU, XIAOFENG | reporter.nih.gov |
| Improving Utilization of Live Donor Kidney Transplant through Effective Patient-Provider Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,936,004 | June 5, 2023 | May 31, 2027 | SIMINOFF, LAURA A. | reporter.nih.gov |
| Identifying the superior ossification pathway for tissue engineered approaches to long bone repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,932,353 | April 1, 2021 | February 28, 2026 | LEACH, J. KENT | reporter.nih.gov |
| Cryopreservation and nanowarming enables whole liver banking for transplantation, cell therapy and biomedical research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,931,299 | February 15, 2023 | January 31, 2027 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Targeting Nuclear HSF1 as a Novel Anti-HCMV Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,927,488 | January 10, 2023 | December 31, 2027 | CHAN, GARY CHING TAO | reporter.nih.gov |
| Development and validation of novel mouse models and expression vectors for characterizing severe alpha-thalassemia pathophysiology and evaluating gene therapy approaches. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,927,121 | June 1, 2023 | May 31, 2027 | RIVELLA, STEFANO | reporter.nih.gov |
| Developing novel therapies to improve blood stem cell transplantation outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,922,704 | April 26, 2023 | April 30, 2027 | GARZON, RAMIRO | reporter.nih.gov |
| Impact of Microbiota on Alloimmune Responses in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,921,704 | November 3, 2014 | November 30, 2025 | ALEGRE, MARIA-LUISA | reporter.nih.gov |
| Derivation of Functional Spermatogonia Stem Cells from Rhesus Macaque iPSCs | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $1,921,633 | September 9, 2019 | June 30, 2024 | EASLEY, CHARLES A. | reporter.nih.gov |
| Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,919,356 | April 1, 2022 | February 28, 2027 | LUO, XUNRONG | reporter.nih.gov |
| Wound healing mechanisms by distinct oral fibroblast population | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $1,917,814 | April 1, 2021 | March 31, 2027 | KO, KANG I | reporter.nih.gov |
| Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,915,320 | June 1, 2021 | February 28, 2025 | YUN, WENBING | reporter.nih.gov |
| Synthetic rescue of antigen-driven T cells and alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,912,839 | August 12, 2019 | December 31, 2023 | SOBOLOFF, JONATHAN A | reporter.nih.gov |
| Biomaterials to enhance the efficacy of MSCs for rotator cuff repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,908,567 | July 1, 2021 | April 30, 2027 | TEMENOFF, JOHNNA S | reporter.nih.gov |
| The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,907,359 | June 1, 2020 | May 31, 2025 | KREISEL, DANIEL | reporter.nih.gov |
| THE NNTC COLLECTS, STORE, AND PROVIDE CLINICAL DATA AND WELL CHARACTERIZED BIOLOGICAL SPECIMENS, INCLUDING POST-MORTEM TISSUE FROM STUDY VOLUNTEERS AND/OR ORGAN DONORS WITH HIV AS WELL AS HIV-NEGATIVE | NIH | National Institute of Mental Health | 2023 to 2025 | $1,905,501 | August 23, 2023 | August 22, 2026 | GELMAN, BENJAMIN | reporter.nih.gov |
| Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,903,303 | July 19, 2022 | April 30, 2027 | BARBAS, ANDREW SERGHIOS | reporter.nih.gov |
| The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival | NIH | National Eye Institute | 2022 to 2025 | $1,896,125 | September 30, 2022 | August 31, 2027 | DANA, REZA | reporter.nih.gov |
| Informing Ethical Translation of Xenotransplantation Clinical Trials | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $1,895,092 | August 9, 2021 | July 31, 2025 | MASCHKE, KAREN JOANN | reporter.nih.gov |
| Home-based Autologous Hematopoietic Stem Cell Transplantation to Improve Outcomes and Decrease Costs | NIH | National Institute on Aging | 2021 to 2024 | $1,889,750 | June 1, 2020 | June 1, 2024 | SUNG, ANTHONY | reporter.nih.gov |
| An Advanced Dermal Regeneration Scaffold for Reconstructive Surgery | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,887,448 | August 15, 2023 | July 31, 2025 | SAPIR LEKHOVITSER, YULIA | reporter.nih.gov |
| Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,887,016 | February 1, 2020 | January 31, 2026 | SCHWARTZ, ROBERT E | reporter.nih.gov |
| Improving Aged Neuromuscular Health and Function | NIH | National Institute on Aging | 2022 to 2025 | $1,878,947 | June 1, 2022 | March 31, 2027 | LAVASANI, MITRA | reporter.nih.gov |
| T Cell Memory in Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,873,569 | February 1, 2001 | April 30, 2026 | LAKKIS, FADI G. | reporter.nih.gov |
| The Cardiac Atlas Project | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,871,310 | January 1, 2014 | June 30, 2025 | MCCULLOCH, ANDREW D. | reporter.nih.gov |
| Cell-free vascular grafts: immunological response and vascular regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,868,150 | April 10, 2020 | March 31, 2026 | ANDREADIS, STELIOS THEOHARIS | reporter.nih.gov |
| Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,867,960 | May 5, 2023 | February 29, 2028 | WANG, RAYMOND YU JEANG | reporter.nih.gov |
| Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,866,060 | January 15, 2022 | March 31, 2027 | KATIYAR, KRITIKA | reporter.nih.gov |
| Peri-operative factors that drive cell-free hemoglobin-mediated primary graft dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,864,753 | August 5, 2022 | July 31, 2027 | SHAVER, CIARA M | reporter.nih.gov |
| Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $1,863,241 | September 15, 2024 | August 31, 2026 | HAN, XU | reporter.nih.gov |
| Long-term Outcomes after Interventions for Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,858,355 | April 1, 2014 | July 31, 2025 | KOCHILAS, LAZAROS K. | reporter.nih.gov |
| Developing Machine Learning Models for Decision Support and Allocation Optimization in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,857,171 | September 4, 2023 | March 31, 2027 | KILIC, ARMAN | reporter.nih.gov |
| Lymph Node Structure and Function in Tolerance: Role of Laminins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,854,000 | April 20, 2015 | May 31, 2025 | BROMBERG, JONATHAN S | reporter.nih.gov |
| Reprogramming reactive glial cells into functional new neurons after SCI | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,850,333 | August 1, 2020 | February 28, 2025 | WU, WEI | reporter.nih.gov |
| Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency | NIH | National Eye Institute | 2021 to 2025 | $1,848,661 | September 1, 2012 | March 31, 2030 | DENG, SOPHIE | reporter.nih.gov |
| Laryngotracheal Reconstruction with Engineered Cartilage | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,843,394 | April 15, 2023 | February 28, 2027 | GOTTARDI, RICCARDO | reporter.nih.gov |
| Multimodal approach investigating the immunomodulatory effect ofneural stem cells in stroke recovery | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,840,475 | August 1, 2008 | January 31, 2026 | STEINBERG, GARY K | reporter.nih.gov |
| The role of bile acid metabolomics in graft-versus-host disease | NIH | National Cancer Institute | 2021 to 2023 | $1,838,884 | April 1, 2018 | October 16, 2023 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Development of a Novel Engineered Tendon Graft to Assist in Repair of Rotator Cuff Injuries | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,836,877 | July 1, 2023 | May 31, 2026 | LARKIN, LISA M | reporter.nih.gov |
| Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,835,791 | July 1, 2023 | May 31, 2028 | TABER, DAVID J. | reporter.nih.gov |
| Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,835,055 | September 30, 2018 | August 31, 2024 | KATIYAR, KRITIKA | reporter.nih.gov |
| Circadian Signatures in Chronic Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,833,797 | August 1, 2020 | May 31, 2025 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | 81 | $107 million | 0 | $0 |
| Duke University | Durham, NC | 50 | $94 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 22 | $92.7 million | 0 | $0 |
| Stanford University | Stanford, CA | 86 | $89.6 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 69 | $88.7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 68 | $85.3 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 52 | $76.9 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 39 | $69.1 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 34 | $68.7 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 39 | $66.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 35 | $64 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 59 | $64 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 39 | $56.4 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 39 | $52.3 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 49 | $48.8 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 32 | $45.4 million | 0 | $0 |
| University of Washington | Seattle, WA | 32 | $45.1 million | 0 | $0 |
| Emory University | Atlanta, GA | 46 | $42.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 26 | $40.6 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 24 | $39.6 million | 0 | $0 |
| Washington University | Saint Louis, MO | 44 | $38.7 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 35 | $37.4 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 22 | $36.7 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 36 | $34.2 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 21 | $34 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 23 | $33.1 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 30 | $31.4 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 12 | $29.4 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 27 | $26.9 million | 0 | $0 |
| PPD Development LP | Wilmington, NC | 1 | $26.7 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 26 | $26.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 19 | $25.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 28 | $24.3 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 21 | $23.3 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 25 | $23.1 million | 0 | $0 |
| Ohio State University | Columbus, OH | 18 | $21.7 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 15 | $21.7 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 20 | $21.1 million | 0 | $0 |
| University of Florida | Gainesville, FL | 25 | $20.8 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 8 | $20.5 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 11 | $20.2 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 13 | $20.1 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 23 | $19.7 million | 0 | $0 |
| Yale University | New Haven, CT | 24 | $18 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 16 | $16.8 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 12 | $16.7 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 12 | $16.6 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 16 | $15 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 9 | $14.7 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 14 | $13.5 million | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 12 | $13.4 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 11 | $12.6 million | 0 | $0 |
| University of Texas at San Antonio | San Antonio, TX | 2 | $12.5 million | 0 | $0 |
| University of Chicago | Chicago, IL | 12 | $11.8 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 12 | $11.6 million | 0 | $0 |
| Cornell University | Ithaca, NY | 7 | $11.4 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 12 | $10.8 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 9 | $10.8 million | 0 | $0 |
| Schepens Eye Research Institute | Boston, MA | 11 | $10.7 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 9 | $10.6 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 9 | $10 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 11 | $9.8 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 9 | $9.7 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 10 | $9.7 million | 0 | $0 |
| Mclean Hospital | Belmont, MA | 2 | $9.6 million | 0 | $0 |
| University of Texas at Dallas | Richardson, TX | 1 | $9.3 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 12 | $8.8 million | 0 | $0 |
| University of Rochester | Rochester, NY | 11 | $8.7 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 22 | $8.6 million | 0 | $0 |
| Brown University | Providence, RI | 4 | $8.5 million | 0 | $0 |
| University of California at Davis | Davis, CA | 12 | $8.4 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 6 | $8.2 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 11 | $8.2 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 5 | $7.9 million | 0 | $0 |
| Technical Resources International, Inc. | Bethesda, MD | 1 | $7.8 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 9 | $7.7 million | 0 | $0 |
| Harvard University | Cambridge, MA | 4 | $7.7 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 4 | $7.6 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 7 | $7.4 million | 0 | $0 |
| Rogosin Institute | New York, NY | 1 | $7.4 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 7 | $6.9 million | 0 | $0 |
| Sylvatica Biotech, Inc. | North Charleston, SC | 4 | $6.8 million | 0 | $0 |
| Pharmain Corporation | Bothell, WA | 1 | $6.8 million | 0 | $0 |
| Bivacor, Inc. | Houston, TX | 3 | $6.5 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 8 | $6.5 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 5 | $6.3 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 6 | $6.2 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 5 | $6.2 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 8 | $6.2 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 6 | $5.9 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 6 | $5.7 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 10 | $5.6 million | 0 | $0 |
| Roswell Park Cancer Institute Corp | Buffalo, NY | 4 | $5.5 million | 0 | $0 |
| Magee-Women's Res Inst and Foundation | Pittsburgh, PA | 4 | $5.4 million | 0 | $0 |
| University of California-San Diego Scripps Inst of Oceanography | La Jolla, CA | 1 | $5.4 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 7 | $5.2 million | 0 | $0 |
| Expanse Bio LLC | North Charleston, SC | 3 | $5.1 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 7 | $5 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 5 | $4.9 million | 0 | $0 |
| Cryocrate, LLC | Columbia, MO | 3 | $4.8 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,042 | $628,532,525 | 0 | $0 |
| 2024 | 1,071 | $577,612,488 | 0 | $0 |
| 2023 | 1,102 | $587,372,721 | 0 | $0 |
| 2022 | 1,123 | $544,630,658 | 0 | $0 |
| 2021 | 1,141 | $548,094,773 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 24 awards here | |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | May 7, 2027 | Not listed | Notice number printed on 5 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 5 awards here | |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-24-253 | NIH | July 17, 2027 | Not listed | Notice number printed on 1 award here | |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | PA-25-080 | NIH | September 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 431 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 431 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 431 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 431 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 431 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 431 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.